Market Tracker

10/24 8:31am ET

Exelixis Inc (NASDAQ:EXEL)

1.64
Data as of Oct 23
 +0.05 / +3.14%
Today’s Change
1.35
Today|||52-Week Range
8.41
-73.25%
Year-to-Date

Today’s Trading

Previous close1.59
Today’s open1.60
Day’s range-- - --
Volume1,480,613
Average volume (3 months)4,197,057
Market cap$310.2M
Dividend yield--
Data as of 10/23/2014

Growth & Valuation

Earnings growth (last year)-44.57%
Earnings growth (this year)-10.63%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-33.96%
P/E ratioNM
Price/Sales36.00
Price/Book4.43

Competitors

 Today’s
change
Today’s
% change
FLXNFlexion Therapeutics...+1.77+10.45%
ARWRArrowhead Research C...+0.17+2.52%
BSTCBiospecifics Technol...+1.10+2.82%
ENZEnzo Biochem Inc+0.13+2.71%
Data as of 10/23/2014

Financials

Next reporting dateOctober 30, 2014
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$31.3M
Annual profit (last year)-$244.8M
Net profit margin-781.03%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial Officer, Senior VP &
Controller
Deborah Burke
Corporate headquarters
South San Francisco, California

Forecasts